ClinicalTrials.Veeva

Menu
A

American Oncology Network | Hope Cancer Care of Nevada

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Paclitaxel
Nivolumab
Carboplatin
Cisplatin
Capecitabine
Ipilimumab
Docetaxel
Gemcitabine Hydrochloride
Pembrolizumab
Etoposide

Parent organization

This site is a part of American Oncology Network

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 110 total trials

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenan...

Enrolling
Multiple Myeloma
Drug: Lenalidomide
Drug: Daratumumab/rHuPH20

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in pa...

Enrolling
Prognostic Stage IA Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Biological: Trastuzumab Emtansine
Other: Quality-of-Life Assessment

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with me...

Enrolling
Recurrent Meningioma
NF2 Gene Mutation
Drug: Vismodegib
Drug: Abemaciclib

Trial sponsors

National Cancer Institute (NCI) logo
Alliance for Clinical Trials in Oncology logo
SWOG Cancer Research Network logo
ECOG-ACRIN Cancer Research Group logo
C
NRG Oncology logo
Tempus AI logo
U
H
National Institutes of Health (NIH) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems